Login / Signup

Advantages of organ-sparing treatment approaches in metastatic kidney cancer.

Iurii VitrukOleg VoylenkoOleksandr StakhovskyOleksii KononenkoMaksym PikulSofiya SemkoBohdan HrechkoDenis KoshelEduard Stakhovsky
Published in: Journal of cancer research and clinical oncology (2022)
Partial nephrectomy is a safe method of choice in patients with metastatic ccRCC. Kidney preservation in a metastatic setting can play a role in reducing potential adverse systemic therapy events and in decreasing the risk for concomitant pathology deterioration.
Keyphrases
  • squamous cell carcinoma
  • small cell lung cancer
  • papillary thyroid
  • squamous cell
  • emergency department
  • robot assisted
  • combination therapy
  • risk assessment
  • decision making
  • young adults
  • climate change
  • childhood cancer